Imagine your gut is like a second brain that talks to your head. Instead of performing risky brain surgery to treat diseases, this project creates tiny, flexible electronic patches for the gut. These patches act like a remote control, sending signals through the gut to fix brain issues without ever touching the skull.
Treating neurological disorders currently requires highly invasive brain surgery. There is a critical lack of tools to modulate brain function through the more accessible enteric nervous system.
Flexible thin-film organic electrode arrays for colon implantation and iontronic devices for localized neurotransmitter delivery.
If you are a device manufacturer dealing with the high risks of invasive brain implants — this project developed flexible, implantable organic electronics that allow for brain modulation via the gut. This provides a less invasive alternative for treating CNS disorders.
If you are a pharma company dealing with imprecise drug targeting for neurological conditions — this project developed iontronic devices for highly localized, fluid-free delivery of neurotransmitters. This allows for precise chemical stimulation of the enteric nervous system.
If you are a biotech firm dealing with the lack of tools to monitor the gut-brain axis — this project developed high-resolution sensing signals in vivo. This enables the prediction and control of brain dysfunction through gut activity.
Based on available project data, there is no specific pricing or unit cost mentioned; the project is currently in the research and development phase.
The project uses thin-film organic electrode arrays and graphene bioelectronics, but based on available project data, industrial scaling metrics have not yet been established.
Based on available project data, specific patent numbers or licensing terms are not listed, though the project involves 7 partners including 2 industry entities.
The project period runs from 2024-03-01 to 2028-02-29, suggesting that clinical readiness will be evaluated toward the end of this window.
The devices are designed as flexible, implantable tools for the colon to target the enteric nervous system, avoiding the need for brain-invasive surgery.
The consortium is a balanced mix of 7 partners across 4 countries, featuring a 29% industry ratio. With 3 universities and 2 research institutions, the project is heavily weighted toward fundamental discovery, but the inclusion of 2 industry partners and 1 SME suggests a clear intent to translate these bioelectronic tools into commercial medical products.
Contact Linkopings Universitet regarding the EnterBio project
Contact us to explore licensing opportunities for gut-brain bioelectronics.
